Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic islets

Diabetes

Volumn 51, Issue SUPPL. 3, 2002, Pages

  Marchetti, Piero ^a   Antonelli, Alessandro ^a   Lupi, Roberto ^a   Marselli, Lorella ^a   Fallahi, Poupak ^a   Nesti, Claudia ^a   Baj, Germano ^b   Ferrannini, Ele ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; AUTOANTIBODY; CALCIUM ION; CD38 ANTIBODY; CD38 ANTIGEN; INSULIN; UNCLASSIFIED DRUG;

CALCIUM CELL LEVEL; CELL CULTURE; CELL FUNCTION; CELL SURVIVAL; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PRIORITY JOURNAL;

EID: 0036895656     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2007.s474     Document Type: Conference Paper

References (21)

1. Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K: Human CD38: A glycoprotein in search of a function. Immunol Today 3: 95-97, 1994
2. Mehta K, Shahid U, Malavasi F: Human CD38, a cell surface molecule with multiple functions. FASEB J 10: 1408-1417, 1996
3. Fernandez JE, Deaglio S, Donati D, Beusan IS, Como F, Aranega A, Forni M, Falini B, Malavasi F: Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. J Biol Regul Homeost Agents 12:81-91, 1998
4. Deaglio S, Dianzani U, Horenstein AL, Fernandez JE, van Kooten C, Bragardo M, Garbarino G, Funaro A, DiVirgilio F, Banchereau J, Malavasi F: A human CD38 ligand: A 120 kDa protein predominantly expressed by endothelial cells. J Immunol 156:727-734, 1996
5. Funaro A, Morra M, Calosso L, Zini MG, Ausiello CM, Malavasi F: Role of the human CD38 molecule in B cell activation and proliferation. Tissue Antigens 49:7-15, 1997
6. Kumagai M, Coustan-Smith E, Murray DJ, Silvennoinen O, Murti KG, Evans WE, Malavasi F, Campana D: Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med 181:1101-1110, 1995
7. Kitanaka A, Ito C, Nishigaki H, Campana D: CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene. Blood 88:590-598, 1996
8. Zupo S, Rugari E, Dono M, Tamborelli G, Malavasi F, Ferrarini M: CD38 signalling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells. Eur J Immunol 24:1218-1222, 1994
9. Kitanaka A, Suzuki T, Ito C, Nishigaki H, Coustan-Smith E, Tanaka T, Kubota Y, Campana D: CD38-mediated signalling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain. J Immunol 162:1952-1958, 1999
10. Kitanaka A, Ito C, Coustan-Smith E, Campana D: CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase. J Immunol 159:184-192, 1997
11. Okamoto H, Takasawa S, Nata K: The CD38-cyclic ADP-ribose signalling system in insulin secretion: Molecular basis and clinical implications. Diabetologia 40:1485-1491, 1997
12. Antonelli A, Baj G, Marchetti P, Fallahi P, Surico N, Pupilli C, Malavasi F, Ferrannini E: Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets. Diabetes 50:985-991, 2001
13. Pupilli C, Giannini S, Marchetti P, Lupi R, Antonelli A, Malavasi F, Takasawa S, Okamoto H, Ferrannini E: Autoantibodies to CD38 (ADP-ribosyl-cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: Effects on insulin release from human islets. Diabetes 48:2309-2315, 1999
14. Ikehata F, Satoh J, Nata K, Tohgo A, Nakazawa T, Karo I, Kobayashi S, Akiyama T, Takasawa S, Toyota T, Okamoto H: Autoantibodies against CD38 (ADP-ribosyl-cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin-dependent diabetes patients. J Clin Invest 102:395-401, 1998
15. Antonelli A, Fallahi P, Nesti C, Pupilli C, Marchetti P, Takasawa S, Okamoto H, Ferrannini E: Anti CD-38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease. Clin Exp Immunol 126:426-431, 2001
16. Marchetti P, Giannarelli R, Cosimi S, Masiello P, Coppelli A, Viacava P, Navalesi R: Massive isolation, morphological and functional characterization, and xenotransplantation of bovine pancreatic islets. Diabetes 44:375-381, 1995
17. Lupi R, Marchetti P, Maffei M, Del Guerra S, Benzi L, Marselli L, Bertacca A, Navalesi R: Effects of acute or prolonged exposure to human leptin on isolated human islet function. Biochem Biophys Res Commun 256:637-641, 1999
18. Malavasi F, Caligaris-Cappio F, Dellabona P, Richiardi P, Carbonara AO: Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells. Hum Immunol 9:9-20, 1984
19. Marselli L, Dotta F, Piro S, Santangelo C, Masini M, Lupi R, Realacci M, del Guerra S, Mosca F, Boggi U, Purrello F, Navalesi R, Marchetti P: Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. J Clin Endocrinol Metab 86:4974-4978, 2001
20. Todisco E, Suzuki T, Srivannaboon K, Coustan-Smith E, Raimondi SC, Behm FG, Kitanaka A, Campana D: CD38 hgation inhibits normal and leukemic myelopoiesis. Blood 95:535-542, 2000
21. Adebanjo OA, Anandatheerthavarada HK, Koval AP, Moonga BS, Biswas G, Sun L, Sodam BR, Bevis PJ, Huang CL, Epstein S, Lai FA, Avadhani NG, Zaidi M: A new function for CD38/ADP-ribosyl cyclase in nuclear Ca2+ homeostasis. Nat Cell Biol 1:409-414, 1999